Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Caredx Inc (NQ: CDNA ) 7.760 -0.440 (-5.37%) Streaming Delayed Price Updated: 4:00 PM EDT, Apr 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 826,608 Open 8.000 Bid (Size) 6.700 (2) Ask (Size) 8.640 (1) Prev. Close 8.200 Today's Range 7.740 - 8.320 52wk Range 4.800 - 12.93 Shares Outstanding 52,627,165 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News CareDx to Report First Quarter 2024 Financial Results April 29, 2024 From CareDx, Inc. Via Business Wire CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) April 19, 2024 From CareDx, Inc. Via Business Wire Performance YTD -35.01% -35.01% 1 Month -24.81% -24.81% 3 Month -21.46% -21.46% 6 Month +50.68% +50.68% 1 Year -6.51% -6.51% More News Read More CareDx Appoints John W. Hanna as its New President and Chief Executive Officer April 16, 2024 From CareDx, Inc. Via Business Wire CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting April 09, 2024 From CareDx, Inc. Via Business Wire Recap: CareDx Q4 Earnings February 28, 2024 Via Benzinga Earnings Outlook For CareDx February 27, 2024 Via Benzinga CareDx Appoints Bryan Riggsbee to Its Board of Directors March 11, 2024 From CareDx, Inc. Via Business Wire CareDx Announces Fourth Quarter and Full Year 2023 Financial Results February 28, 2024 From CareDx, Inc. Via Business Wire CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference February 27, 2024 From CareDx, Inc. Via Business Wire CareDx to Report Fourth Quarter and Full Year 2023 Financial Results February 21, 2024 From CareDx, Inc. Via Business Wire CareDx: Q3 Earnings Insights November 08, 2023 Via Benzinga Earnings Outlook For CareDx November 07, 2023 Via Benzinga CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings February 21, 2024 From CareDx, Inc. Via Business Wire 3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List February 06, 2024 Via InvestorPlace CareDx Issues Statement in Patent Infringement Case January 26, 2024 From CareDx, Inc. Via Business Wire Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle January 17, 2024 Via Investor's Business Daily Topics Intellectual Property Exposures Intellectual Property CareDx Adds to AlloSure Kidney and HeartCare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter Symposium January 11, 2024 From CareDx, Inc. Via Business Wire CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023 January 09, 2024 From CareDx, Inc. Via Business Wire CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence December 19, 2023 From CareDx, Inc. Via Business Wire 12 Health Care Stocks Moving In Thursday's Pre-Market Session November 09, 2023 Via Benzinga CareDx Reports Third Quarter 2023 Results November 08, 2023 From CareDx, Inc. Via Business Wire CareDx to Report Third Quarter 2023 Financial Results November 02, 2023 From CareDx, Inc. Via Business Wire 12 Health Care Stocks Moving In Thursday's Pre-Market Session November 02, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session November 01, 2023 Via Benzinga CareDx Announces CEO Transition November 01, 2023 From CareDx, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
